Optimismm of POMALYST omit positive results for treating a malicious disease: Celegne corporation
SMM evaluated the efficacy and safety of POMALYST/IMNOVID (pomalidomide) plus bortezomib and low-dose dexamethasone (PVd) versus bortezomib and low-dose dexamethasone in patients with relapsed/refractory...
Kanuma ensuressurvival from Lysosomal Acid Lipse Deficiency; A Liver Disease
Alexion Pharmaceuticals, Inc. announced that the combined interim data from two ongoing open-label studies, VITAL and CL-08, show a 3-year survival estimate of 68%...
GSK’S B vaccine prevents harmful disease among children; U.S FDA applauds
GlaxoSmithKline plc announced that it has received Breakthrough Therapy Designation from the U.S. FDA for its meningitis B vaccine Bexsero for the development...
Janssen Pierce To Globally Collabrate With Theravance Biopharma For Oral, Pan-Jak Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today their entry into a worldwide collaboration with an affiliate of Theravance Biopharma, Inc. to...
Roche’s TECENTRIQ®and Avastin® reduced the risk of disease worsening or death by 26 percent in certain advanced kidney cancer cases
Roche announced results from the positive Phase III IMmotion151 study of TECENTRIQ® (atezolizumab) and Avastin® (bevacizumab) as a first-line treatment for advanced or metastatic...
Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders
Shire plc , the global biotechnology leader in rare diseases, today announced the range of real-world and long-term research it will present at the...
Treatment and Management of Rare Lysosomal Diseases highlighted by shire at Global Conference
Shire plc the global biotechnology leader in rare diseases, today announced that it will have 12 presentations, including 11 posters and one oral presentation,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...